Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Onpattro
Pharma
Market growth will help spark sales of Amvuttra, Alnylam says
As Alnylam anticipates the potential expansion of Amvuttra to treat patients for ATTR-CM, the company is emphasizing the growth of the market.
Kevin Dunleavy
Feb 13, 2025 2:08pm
Alnylam sees Amvuttra as potential standard of care in ATTR-CM
Aug 30, 2024 10:06am
FDA spurns Alnylam's Onpattro in ATTR-CM despite adcomm backing
Oct 9, 2023 9:54am
Pfizer's tafamidis will hold its own against new meds: analysts
Sep 18, 2023 3:05pm
Alnylam wins expert backing for Onpattro in rare heart disease
Sep 13, 2023 5:30pm
FDA casts doubt on Alnylam's Onpattro in ATTR-CM
Sep 11, 2023 11:15am
